Sylvest Advisors’s Johnson & Johnson JNJ Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2026
Q1
$1.43M Sell
5,850
-101
-2% -$23.5K 0.76% 16
2025
Q4
$1.23M Buy
5,951
+125
+2% +$24.7K 0.66% 18
2025
Q3
$1.08M Buy
5,826
+386
+7% +$66.1K 0.58% 20
2025
Q2
$831K Buy
5,440
+19
+0.4% +$2.92K 0.48% 24
2025
Q1
$899K Sell
5,421
-62
-1% -$9.7K 0.56% 24
2024
Q4
$793K Buy
+5,483
New +$850K 0.49% 30

Other funds holding JNJ

Sylvest Advisors's JNJ Position: Q1 2026 in Review

Sylvest Advisors reduced its Johnson & Johnson (JNJ) stake by 1.7% in Q1 2026, selling an estimated $23.5K and leaving 5,850 shares worth $1.43M. The position accounts for 0.76% of the portfolio, ranked #16.

Sylvest Advisors first reported a position in JNJ in Q4 2024 and has held it in 6 quarters since. 4,613 funds tracked by Wall St. Rank hold JNJ as of Q1 2026.

  • Sylvest Advisors held 5,850 shares of Johnson & Johnson worth $1.43M as of Q1 2026.
  • Sylvest Advisors sold 101 Johnson & Johnson shares in Q1 2026, an estimated $23.5K.
  • Johnson & Johnson made up 0.76% of Sylvest Advisors's portfolio in Q1 2026, its #16 holding.
  • Sylvest Advisors first reported a position in Johnson & Johnson in Q4 2024 and has held it in 6 quarters since.
  • 4,613 funds tracked by Wall St. Rank held Johnson & Johnson as of Q1 2026.

Based on Sylvest Advisors's 13F filing for Q1 2026, filed 22 Apr 2026.